newsfilter
← Latest News
Earnings Call Transcripts·

REVEAL-2 Phase 3 Topline Results - VIRIDIAN THERAPEUTICS INC

Good morning, ladies and gentlemen, and welcome to the Viridian Therapeutics Conference Call to review top-line results from the REVEAL-2 Phase 3 Clinical Trial in Chronic Thyroid Eye Disease. At this time, participants

Company
VIRIDIAN THERAPEUTICS INC
Keywords
VIRIDIAN THERAPEUTICS INC